Table of contents
Orthodromic atrioventricular reentrant tachycardia
Guidelines
Key sources
The following summarized guidelines for the management of orthodromic atrioventricular reentrant tachycardia are prepared by our editorial team based on guidelines from the European Society of Cardiology (ESC 2020) and the American Heart Association (AHA/HRS/ACC 2016).
1
2
Medical management
Acute management
As per ESC 2020 guidelines:
Administer intravenous adenosine (8-18 mg bolus) for acute management of hemodynamically stable patients with orthodromic AVRT if vagal maneuvers fail.
B
Consider administering IV formulations of the following medications for acute management of hemodynamically stable patients with orthodromic AVRT if vagal maneuvers and adenosine fail:
nondihydropyridine CCBs, i.e. verapamil or diltiazem
C
β-blockers, i.e. esmolol or metoprolol in the absence of decompensated HF
C
More topics in this section
Ongoing management
Nonpharmacologic interventions
Therapeutic procedures
Synchronized electrical cardioversion
As per ESC 2020 guidelines:
Perform synchronized direct current cardioversion for acute management of hemodynamically unstable patients with orthodromic AVRT.
B
Perform synchronized direct current cardioversion for acute management of hemodynamically stable patients with orthodromic AVRT if drug therapy fails to convert or control the tachycardia.
B
More topics in this section
Catheter ablation